Top compounds associated with response to DYTN


Feature Type Standardized
Nominal ANOVA
mRNA YK 4-279 GDSC1000 pan-cancer AAC 0.064 0.07
mRNA AZD7762 GDSC1000 pan-cancer AAC 0.057 0.07
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.08
mRNA cimetidine CTRPv2 pan-cancer AAC 0.11 0.08
mRNA EHT 1864 GDSC1000 pan-cancer AAC -0.059 0.08
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.08
mRNA BRD-K50799972 CTRPv2 pan-cancer AAC 0.064 0.08
mRNA Bicalutamide GDSC1000 pan-cancer AAC -0.058 0.08
mRNA PIK-93 CTRPv2 pan-cancer AAC -0.059 0.08
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.08
Download CSV